Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

11,350articles mentioning institutions

22,378institution mentions

9,137distinct institutions extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted institutions

Showing 1,621–1,680 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.

Uganda Heart Institute2 Uganda National Council for Science and Technology2 Unit2 United Kingdom Prospective Diabetes Study2 Unity Health Toronto2 Unity Health Toronto Research Ethics Board2 Universitair Ziekenhuis Brussel2 University Children’s Hospital in Belgrade2 University Clinical Center of Serbia2 University Hospital Coventry and Warwickshire2 University Hospital Essen2 University Hospital Galway2 University Hospital Zurich2 University Hospital of Modena2 University Hospital of North Norway2 University Hospitals Coventry and Warwickshire NHS Trust2 University Hospitals Sussex2 University Hospitals of North Midlands2 University Malaya Medical Centre2 University Medical Centre Utrecht2 University of Adelaide2 University of Amsterdam2 University of Athens2 University of Bonn2 University of Bristol2 University of Freiburg2 University of Galway2 University of Ghana2 University of Houston2 University of Lagos2 University of Leipzig2 University of Malaya Medical Centre2 University of Nairobi2 University of North Carolina2 University of North Carolina at Chapel Hill2 University of Nottingham2 University of Otago2 University of Ottawa2 University of Pretoria2 University of Queensland HREC2 University of Queensland Human Research Ethics Committee2 University of Regensburg2 University of Southampton2 University of Southern California2 University of Surrey2 University of Texas Health Science Center at Houston2 University of Toronto Health Sciences Research Ethics Board2 University of Utah Office of Comparative Medicine2 University of Washington Institutional Review Board2 University of Zambia2 University of the Witwatersrand2 Université du Québec à Rimouski2 Upper Gastrointestinal Cancer Early Detection Program2 Ural Children Eye Study2 Ural Eye and Medical Study2 Ural Very Old Study2 Valve Academic Research Consortium2 Vancouver General Hospital2 Vanderbilt University2 Vector Laboratories2

View all 9,137 institutions on one page

Articles mentioning institutions

11,350 articles · page 475 of 946

P.186 Clinical risk factors for the development of lower limb ulcers in patients with systemic sclerosis: a cohort study of 239 patients

jsrd · abstract · 2026-06-05 · 1 matching annotations

94.9%

Yokohama City University Hospital anticentromere systemic sclerosis (SSc)SSc interstitial lung disease (ILD)ILD pulmonary arterial hypertension

…trospective chart reviews of 239 patients diagnosed with SSc at Yokohama City University Hospital from January 2018 to March 2025. Clinical characteristics, labo…

P.189 Filmed interviews elucidate diverse patient experiences with digital ulcers

jsrd · abstract · 2026-06-05 · 1 matching annotations

87.6%

Health and Care Research Wales SSc scleroderma Health Research Authority DU Digital ulcers

…hical approval was granted by the Health Research Authority and Health and Care Research Wales (REC Reference 23/NW/0206). Participants diagnosed with a histo…

P.195 Non-pharmacological management of raynaud’s phenomenon in systemic sclerosis: a systematic review

jsrd · abstract · 2026-06-05 · 1 matching annotations

80.8%

CENTRAL systemic sclerosis (SSc)SSc-RP MEDLINE Embase

… and Methods We searched MEDLINE, Embase, CINAHL, PsycINFO, and CENTRAL from inception to 10 April 2024, with additional citation searc…

P.197 An audit of iloprost delivery in a tertiary scleroderma specialist centre

jsrd · abstract · 2026-06-05 · 1 matching annotations

87.9%

tertiary SSc referral centre Iloprost bosentan SSc

…f patients receiving Iloprost in a dedicated day-case unit at a tertiary SSc referral centre in London, UK was collected retrospectively over 6 months (Augu…

P.204 Mycophenolate mofetil in limited scleroderma reduces the risk of vascular complication leading to treatment escalation: emulation of a target trial using time-dependent propensity score-matching

jsrd · abstract · 2026-06-05 · 1 matching annotations

77.2%

Italian SPRING registry Mycophenolate Mofetil systemic sclerosis (SSc)interstitial lung disease MMF interstitial lung disease (ILD)cutaneous fibrosis iloprost lcSSc ILD+3 more

…ons.Material and Methods Clinical data of lcSSc patients in the Italian SPRING registry were retrospectively compared based on MMF use at any stage of …

P.208 Rethinking skin assessment: analysis of individual rodnan skin sites scores in early diffuse systemic sclerosis using the EUSTAR cohort

jsrd · abstract · 2026-06-05 · 1 matching annotations

76.5%

EUSTAR systemic sclerosis (SSc)dcSSc

…ods Patients from the European Scleroderma Trials and Research (EUSTAR) cohort with dcSSc, fulfilling ACR/EULAR classification criteri…

P.217 Features of patients with morphea: a single center 15-year experience

jsrd · abstract · 2026-06-05 · 1 matching annotations

78.4%

Department of Rheumatology and Clinical Immunology morphea hydroxychloroquine Sjögren’s disease methotrexate Hashimoto thyroiditis Crohn’s disease erythema nodosum type 1 diabetes cyclosporine+1 more

…ective analysis of all patients with morphea followed-up by the Department of Rheumatology and Clinical Immunology, Larissa, Greece was performed. Demographics and disease relate…

P.223 Comparison of artificial intelligence and rheumatologists in nailfold capillaroscopic evaluation

jsrd · abstract · 2026-06-05 · 1 matching annotations

75.8%

…ted for publication in Revista da Associação Médica Brasileira (RAMB), October 22, 2025. In press.Abstract P.223 Figure 1…

P.227 Identification of lipidomic biomarkers associated with disease progression in systemic sclerosis

jsrd · abstract · 2026-06-05 · 1 matching annotations

82.2%

Nova Medical Testing Inc.SSc DcSSc

…inical subset of SSc were identified using LipidScreener 1.0.0 (Nova Medical Testing Inc.) and classified according to a three-tier identification method…

P.229 Neutrophil-to-lymphocyte ratio as a biomarker for disease onset and severity in systemic sclerosis – real-world data from a large healthcare provider in Israel

jsrd · abstract · 2026-06-05 · 1 matching annotations

83.5%

Maccabi Healthcare Services systemic sclerosis systemic sclerosis (SSc)steroid interstitial lung disease pulmonary hypertension PAH SSc

…l and Methods Adult patients with systemic sclerosis (SSc) from Maccabi Healthcare Services (MHS), a 2.7-million-member Israeli health provider, were ident…

P.232 Early diagnosis of SSc-ILD progression: a comparative study of high-resolution chest CT assessment with visual and artificial intelligence-assisted scoring

jsrd · abstract · 2026-06-05 · 1 matching annotations

84.8%

GE Healthcare systemic sclerosis (SSc)Progressive interstitial lung disease (ILD)SSc-ILD

…luated by AI-assisted analysis (Thoracic VCAR, AW SERVER v.3.2, GE Healthcare) and by two chest radiologists for semi-quantitative analysis o…

P.245 Serum type I interferon activity as a biomarker of morbimortality in systemic sclerosis independent of cutaneous subset

jsrd · abstract · 2026-06-05 · 1 matching annotations

78.1%

EudraCT systemic sclerosis (SSc)Myriad RBM CCL2 CCL8 CCL19 dcSSc SSc targeted therapies

… The combined morbi-mortality endpoint from the MINIMISE trial (EudraCT: 2019-004139-21) was used as clinical outcome, with time-to-eve…